Listed

Kopin Corp: Form 10-Q for the period ended Sep 30, 2023

Filed with the SEC on Nov 13, 2023 and accepted by EDGAR at Nov 13, 2023, 07:01 ET.

Share

Management's discussion and analysis

As filed, 22,395 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “could,” “would,” “seeks,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this report, except as may otherwise be required by the federal securities laws.

We have identified the following important factors that could cause actual results to differ materially from those discussed in our forward-looking statements. Such factors may be in addition to the risks described in Part I, Item 1A, “Risk Factors;” Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. These factors include: our ability to source semiconductor components and other raw materials used in the manufacturing of our products; our ability to prosecute and defend our proprietary technology aggressively or successfully; our ability to retain personnel with experience and expertise relevant to our business; our ability to invest in research and development to achieve profitability even during periods when we are not profitable; our ability to continue to introduce new products in our target markets; our ability to generate revenue growth and positive cash flow, and reach profitability; the strengthening of the U.S. dollar and its effects on the price of our products in foreign markets; the impact of new regulations and customer demands relating to conflict minerals; our ability to obtain a competitive advantage in the wearable technologies market through our extensive portfolio of patents, trade secrets and non-patented know-how; our ability to grow within our targeted markets; the importance of small form factor displays in the development of defense, consumer, and industrial products such as thermal weapon sights, safety equipment, virtual and augmented reality gaming, training and simulation products and metrology tools; the suitability of our properties for our needs for the foreseeable future; our expectation not to pay cash dividends for the foreseeable future and to retain earnings for the development of our businesses; our need to achieve and maintain positive cash flow and profitability; and our expectation that if we do not achieve and maintain positive cash flow and profitability; our financial condition will ultimately be materially adversely affected, and we will be required to reduce expenses, including our investments in research and development or raise additional capital and our ability to support our operations and capital needs for at least the next twelve months through our available cash resources.

Overview

We are a leading developer, manufacturer and seller of miniature displays and optical lenses (our “components”) for sale as individual displays, components, modules or higher-level subassemblies. We also license our intellectual property through technology license agreements. Our component products are used in highly demanding high-resolution portable military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. Our products enable our customers to develop and market an improved generation of products for these target applications.

The following discussion should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and our unaudited condensed consolidated financial statements included in this Form 10-Q.

Results of Operations

Our interim period results of operations and period-to-period comparisons of such results may not be indicative of our future operating results. Additionally, we use a fiscal calendar, which may result in differences in the number of work days in the current and comparable prior interim periods and could affect period-to-period comparisons. The following discussions of comparative results among periods, including the discussion of results by display application, should be viewed in this context.

Revenues. For the three and nine months ended September 30, 2023 and September 24, 2022, our revenues by display application, which include product sales and amounts earned from research and development contracts (“R&D”), were as follows:

(In thousands)

Three months ended September 30, 2023 Three months ended September 24, 2022 Nine months ended September 30, 2023 Nine months ended September 24, 2022
Defense $4,996 $5,851 $16,482 $17,695
Industrial 310 1,727 2,118 4,889
Consumer 200 676 573 1,182
R&D 4,956 3,375 11,737 11,089
License and royalties 136 100 907 362
Total Revenues $10,598 $11,729 $31,817 $35,217

Sales of our products for Defense applications include systems used by the military both in the field and for training and simulation. The decrease in Defense applications revenues for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 24, 2022 was primarily due to decreases in revenues from products used in pilot helmets and thermal weapon sight systems for soldiers.

Industrial applications revenue represents customers who purchase our display products for use in 3D metrology equipment and headsets used for applications in manufacturing, distribution and public safety. Our 3D metrology customers are primarily located in Asia and sell to Asian contract manufacturers who use the 3D metrology machines for quality control purposes. The decreases in Industrial applications revenues for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 24, 2022 was due to a decline in sales of products for use in 3D metrology equipment and headsets.

Our displays for Consumer applications are used primarily in thermal imaging products and recreational rifles and hand-held scopes. The decreases in Consumer applications revenues for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 24, 2022 were primarily due to a decrease in sales for hand-held thermal imagers.

R&D revenues increased in the three months ended September 30, 2023 as compared to the three months ended September 24, 2022 primarily due to the sale of thermal weapon sight design for $1.9 million which was partially offset by a decline in funding for display systems used in U.S. defense programs as certain programs transitioned to production programs. R&D revenues increased in the nine months ended September 30, 2023 as compared to the nine months ended September 24, 2022 primarily due to the sale of thermal weapon sight design for $1.9 million which was partially offset by a decline in funding for U.S. defense programs as certain programs transitioned to production programs.

On January 5, 2023, the Company entered into a Technology License Agreement and an Asset Purchase Agreement (the “LST Agreements”) with Lightning Silicon Technology, Inc. (“LST”). Pursuant to the LST Agreements, the Company transferred in-process development contracts with two customers. Included in R&D revenues for the nine months ended September 30, 2023 and September 24, 2022 is approximately $400,000 and $500,000, respectively, related to OLED development programs with the transferred development contracts.

International revenues represented 6% and 12% of total revenues for the three and nine months ended September 30, 2023, respectively, and 20% and 18% of total revenues for the three and nine months ended September 24, 2022, respectively. We categorize our revenues as either domestic or international based upon the delivery destination of our product. For example, if the customer is located in Asia or if a U.S. customer has its Asian contract manufacturer order product from us and we deliver the product to Asia, we categorize both of these sales as international. In addition, if we earn royalties on sales from a customer, the royalties are categorized as domestic or international based on how the product revenues are categorized. The decrease in international revenues was a result of a decrease in sales of products for 3D AOI metrology equipment and industrial wearable headset applications. Our international sales are primarily denominated in U.S. currency. Consequently, a strengthening of the U.S. dollar could increase the price in local currencies of our products in foreign markets and make our products relatively more expensive than competitors’ products that are denominated in local currencies, which could lead to a reduction in sales or profitability in those foreign markets. We have not taken any protective measures against exchange rate fluctuations, such as purchasing hedging instruments with respect to such fluctuations, because of the historically stable exchange rate between the British Pound Sterling (the functional currency of our U.K. subsidiary) and the U.S. dollar. Foreign currency translation impact on our results, if material, is described in further detail under “Item 3. Quantitative and Qualitative Disclosures About Market Risk” section below.

Cost of Product Revenues. Cost of product revenues, which is comprised of materials, labor and manufacturing overhead related to the production of our products for the three and nine months ended September 30, 2023 and September 24, 2022, were as follows:

(In thousands, except for percentages)

Three Months Ended September 30, 2023 Three Months Ended September 24, 2022 Nine Months Ended September 30, 2023 Nine Months Ended September 24, 2022
Cost of product revenues $5,438 $7,987 $17,759 $23,676
Cost of product revenues as a % of net product revenues 99% 97% 93% 100%

Cost of product revenues as a percentage of net product revenues for the three months ended September 30, 2023, as compared to the three months ended September 24, 2022,was essentially flat. The slight decrease in cost of product revenues as a percentage of net product revenues for the nine months ended September 30, 2023, as compared to the nine months ended September 24, 2022, was primarily due to lower labor costs as a result of a reduction in force in the first quarter of 2023 and lower material costs for warranty issues of approximately $450,000.

During 2021, we became aware of global shortages of semiconductor components. During 2022, our manufacturing was impacted by a shortage of several semiconductor components from our normal vendors that are necessary to manufacture our products. For some components we were able to identify and use other sources for the components but for some components primarily used in defense related products, we were able to avail ourselves of alternate components because their use would have required a requalification of our product by our customer. The shortage of certain semiconductor components situation is very dynamic, and we rely on our vendors to provide information about the vendors that they use.

Research and Development. R&D expenses are incurred in support of internal display development programs and programs funded by agencies or prime contractors of the U.S. government and commercial partners. R&D costs include staffing, purchases of materials and laboratory supplies, circuit design costs, fabrication, and packaging of display products, and overhead. In fiscal year 2023, we expect our R&D expenditures to be related to our display products, overlay weapon sights and OLED display technologies. Funded and internal R&D expenses are combined in research and development expenses in the condensed consolidated statement of operations. R&D expenses for the three and nine months ended September 30, 2023 and September 24, 2022 were as follows:

(In thousands)

Three Months Ended September 30, 2023 Three Months Ended September 24, 2022 Nine Months Ended September 30, 2023 Nine Months Ended September 24, 2022
Funded $2,346 $1,843 $6,179 $8,391
Internal 744 1,598 2,355 5,604
Total research and development expense $3,090 $3,441 $8,534 $13,995

Funded R&D expense for the three months ended September 30, 2023 increased as compared to the three months ended September 24, 2022 primarily due to increased spending on U.S. defense programs. Funded R&D expense for the nine months ended September 30, 2023 decreased as compared to the nine months ended September 24, 2022 primarily due to decreased spending on U.S. defense programs as certain programs transitioned to production programs. Internal R&D expenses for the three and nine months ended September 30, 2023 decreased compared to the three and nine months ended September 24, 2022 primarily due to a decrease in OLED development costs.

On January 5, 2023, the Company entered into the LST Agreements with LST. Drs. John Fan, the Company’s former President, CEO, and Chairman of the Board, Boryeu Tsaur, a former Executive Vice President of the Company and Hong Choi, the Company’s former Chief Technology Officer, terminated their employment with the Company and became investors in and members of the management team of LST. In addition, approximately 20 employees terminated their employment with the Company and joined LST. These individuals were primarily involved with internal R&D projects and the termination of the programs they were working on and their employment is the primary reason for the decrease in internal R&D expense.

Selling, General and Administrative. Selling, general and administrative (“S,G&A”) expenses consist of the expenses incurred by our sales and marketing personnel and related expenses, and administrative and general corporate expenses. S,G&A expenses for the three and nine months ended September 30, 2023 and September 24, 2022 were as follows:

(In thousands, except for percentages)

Three Months Ended September 30, 2023 Three Months Ended September 24, 2022 Nine Months Ended September 30, 2023 Nine Months Ended September 24, 2022
Selling, general and administration expense $4,799 $4,320 $15,913 $13,112
Selling, general and administration expense as a % of revenues 45% 37% 50% 37%

The increase in S,G&A expense for the three months ended September 30, 2023, as compared to the three months ended September 24, 2022, was primarily due to an increase in legal expense, stock compensation, and marketing and website development expenses partially offset by lower cash compensation and benefits expense. The increase in S,G&A expense for the nine months ended September 30, 2023, as compared to the nine months ended September 24, 2022, was primarily due to an increase in legal expense, stock compensation and marketing and website development expenses partially offset by lower information technology, insurance, and cash compensation and benefits expense.

Other Income (Expense), net. Other income (expense), net, is primarily composed of interest income, foreign currency transaction and remeasurement gains and losses incurred by our U.K.-based subsidiary and other non-operating income items. Other income (expense), net, for the three and nine months ended September 30, 2023 and September 24, 2022 was as follows:

(In thousands)

Three Months Ended September 30, 2023 Three Months Ended September 24, 2022 Nine Months Ended September 30, 2023 Nine Months Ended September 24, 2022
Other income (expense), net $317 $(2,094) $(2,752) $2,506

During the three and nine months ended September 30, 2023 and September 24, 2022, we recorded foreign currency losses of less than $0.1 million and $0.2 million. Other expense for the nine months ended September 30, 2023 includes $3.3 million of impairment losses on equity investments. Other income for the first quarter of 2022 includes a gain of $4.7 million resulting from an observable price change in an equity investment.

Tax Provision. We recorded a provision for income taxes of less than $0.1 million and approximately $0.1 million in the three and nine months ended September 30, 2023 and September 24, 2022, respectively.

Net Loss Attributable to Noncontrolling Interest. In the first quarter of 2023, we acquired the remaining interest in eMDT America (“eMDT”). Net loss attributable to noncontrolling interest on our condensed consolidated statements of operations represents the 20% portion of the results of operations of eMDT which is allocated to the stockholders of the equity interests not owned by us in 2022. The change in net loss attributable to noncontrolling interest is the result of the change in the results of operations of eMDT for the three and nine months ended September 24, 2022.

Net Loss Attributable to Kopin Corporation. We incurred net losses attributable to Kopin Corporation of $2.5 million and $13.3 million during the three and nine months ended September 30, 2023, respectively, compared to net losses attributable to Kopin Corporation of $6.1 million and $13.2 million during the three and nine months ended September 24, 2022, respectively. The decrease in the net loss attributable to Kopin Corporation during the three months ended September 30, 2023 compared to the three months ended September 24, 2022 was partially due to a $1.0 million warranty charge due to a supply chain related quality issue and a $2.0 million impairment charge on an equity investment, both occurring during the three months ended September 24, 2022

Liquidity and Capital Resources

At September 30, 2023 and December 31, 2022, we had cash and cash equivalents, including restricted cash, and marketable debt securities of $21.7 million and $12.9 million, respectively, and working capital of $29.3 million and $16.4 million, respectively. The change in cash and cash equivalents and marketable securities was primarily due to gross proceeds of $22.9 million received from the sale of 17,000,000 shares of common stock and the pre-funded warrants to purchase up to 6,000,000 shares of common stock at a public offering price of $0.99 per share. The reader is referred to Note 8 Stockholders’ Equity and Stock-Based Compensation. Our cash and cash equivalents and liquidity could be adversely affected by any amounts that become payable in connection with any adverse results from any litigation we are, or may become, involved in.

We believe that our existing cash and cash equivalents will be adequate to satisfy our current operating plans for at least the next twelve months from the issuance of these financial statements. We have in the past sold equity securities through at-the-market equity offerings and in the traditional fashion of significant equity offerings. Nonetheless, management monitors the capital markets on an ongoing basis and may consider raising capital if favorable market conditions develop. If our actual results are less than projected or we need to raise capital for additional liquidity, we may be required to do additional equity financing, reduce expenses, or enter into a strategic transaction. However, management can make no assurance that we will be able to raise additional capital, reduce expenses sufficiently, or enter into a strategic transaction on terms acceptable to us, or at all.

During the nine months ended September 24, 2022, we sold 2.2 million shares of common stock and 0.1 million shares of treasury stock for gross proceeds of $2.9 million (average of $1.26 per share) before deducting broker expenses paid by us of less than $0.1 million, pursuant to the Company’s At-The-Market Equity Offering Sales Agreement dated as of March 5, 2021 (the “ATM Agreement”) with Stifel, Nicolaus & Company, Incorporated, as agent, under which we may sell up to $50 million of our common stock. We have approximately $41.4 million worth of common stock remaining available for sale under the ATM Agreement.

Cash, cash equivalents, restricted cash and marketable debt securities held in U.S. dollars at September 30, 2023 and December 31, 2022 were as follows:

September 30, 2023 December 31, 2022
Domestic locations $21,549,626 $11,778,324
International locations 46,291 629,793
Subtotal cash, cash equivalents, restricted cash and marketable debt securities held in U.S. dollars 21,595,917 12,408,117
Cash and cash equivalents held in other currencies and converted to U.S. dollars 114,243 239,539
Total cash, cash equivalents, restricted cash and marketable debt securities $21,710,160 $12,647,656

We have no plans to repatriate the cash and cash equivalents held in our foreign subsidiary Forth Dimension Displays, Ltd. and, as such, we have not recorded any deferred tax liability with respect to such cash.

We expect to expend between $1.0 million and $2.0 million on capital expenditures in 2023.

Market risk

As filed, 1,853 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We invest our excess cash in high-quality U.S. government, government-backed (e.g., Fannie Mae, FDIC guaranteed bonds and certificates of deposit) and corporate debt instruments, which bear lower levels of relative risk. We believe that the effect, if any, of reasonably possible near-term changes in interest rates on our financial position, results of operations and cash flows should not be material to our cash flows or income. It is possible that interest rate movements would increase our unrealized gain or loss on debt securities. We are exposed to changes in foreign currency exchange rates primarily through our translation of our foreign subsidiaries’ financial position, results of operations, and transaction gains and losses as a result of non-U.S. dollar denominated cash flows related to business activities in Europe, and remeasurement of U.S. dollars to the British pound, the functional currency of our U.K. subsidiaries. We are also exposed to the effects of exchange rates in the purchase of certain raw materials, which are in U.S. dollars, but the price on future purchases is subject to change based on the relationship of the Japanese yen to the U.S. dollar. We do not currently hedge our foreign currency exchange rate risk. We estimate that any market risk associated with our international operations or investments is unlikely to have a material adverse effect on our business, financial condition, or results of operation. Our portfolio of marketable debt securities is subject to interest rate risk although our intent is to hold securities until maturity. The credit rating of our investments may be affected by the underlying financial health of the guarantors of our investments. We use silicon wafers but do not enter into forward or futures hedging contracts to mitigate against risks related to the price of silicon.

Controls and procedures

As filed, 2,285 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of September 30, 2023, the Company conducted an evaluation under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer (its principal executive officer and principal financial officer, respectively) regarding the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of September 30, 2023, as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The term “disclosure controls and procedures” means controls and other procedures that are designed to ensure that information required to be disclosed by the Company in reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the requisite time periods and that such disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our management concluded that, as of September 30, 2023, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 451 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business and financial results are subject to numerous risks and uncertainties. As a result, the risks and uncertainties discussed in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 should be carefully considered. There have been no material changes in the assessment of our risk factors from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-07-02 to 2023-09-30$10.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2023-01-01 to 2023-09-30$31.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2023-07-02 to 2023-09-30$3.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2023-01-01 to 2023-09-30$8.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2023-07-02 to 2023-09-30$4.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2023-01-01 to 2023-09-30$15.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-07-02 to 2023-09-30−$2.7mus-gaap:OperatingIncomeLoss
Operating income9 months2023-01-01 to 2023-09-30−$10.4mus-gaap:OperatingIncomeLoss
Income tax3 months2023-07-02 to 2023-09-30$39.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2023-01-01 to 2023-09-30$117.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-07-02 to 2023-09-30−$2.5mus-gaap:NetIncomeLoss
Net income9 months2023-01-01 to 2023-09-30−$13.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-07-02 to 2023-09-30−$0.02us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2023-01-01 to 2023-09-30−$0.12us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-07-02 to 2023-09-30−$0.02us-gaap:EarningsPerShareBasic
Basic EPS9 months2023-01-01 to 2023-09-30−$0.12us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-07-02 to 2023-09-30110,360,814 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2023-01-01 to 2023-09-30108,436,146 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2023-01-01 to 2023-09-30−$11.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2023-09-30$9.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-09-30$45.4mus-gaap:AssetsCurrent
Total assetsAt period end2023-09-30$54.6mus-gaap:Assets
Current liabilitiesAt period end2023-09-30$16.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-09-30$20.2mus-gaap:Liabilities
Shareholders' equityAt period end2023-09-30$34.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-23-040304. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.